How is the Abivax - ADR today?

The Abivax - ADR today is trading in the down by -6.28% at 5.67.

How has Abivax - ADR performed historically?

The Abivax - ADR is currently trading down -6.28% on an intraday basis in the past week the index fell -5.66%. The index has been down -29.83% in the past quarter and fell -59.21% in the past year. You can view this in the overview section.

What is Abivax - ADR Annual Net Profit?

Abivax - ADR Annual Net Profit fell 19.29% in the last year to $176.24 M. Its sector's average net profit growth for the last fiscal year was -11.1%.

What is Abivax - ADR Stock Price?

Abivax - ADR Stock Price fell 59.21% and underperformed its sector by 77.88% in the past year.

What is Abivax - ADR Debt to Equity Ratio?

Abivax - ADR Debt to Equity Ratio of 2.4 is higher than 1. This implies that company assets are financed through debt.

What is Abivax - ADR Return on Equity(ROE)?

Abivax - ADR Return on Equity(ROE) for the last financial year was -148.98%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Abivax - ADR Mutual Fund Holding?

Abivax - ADR Mutual Fund Holding increased by 0.47% in the last quarter to 3.72.

What is Abivax - ADR Interest Coverage Ratio?

Abivax - ADR Interest Coverage Ratio is -13.18, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Abivax - ADR Institutional Holding?

Abivax - ADR Institutional Holding increased by 2.36% in the last quarter to 49.44.

Abivax - ADR XNAS: ABVX

Abivax - ADR Live Share Price Today, Share Analysis and Chart

Name: Abivax - ADR: Is Infosys Ltd. worth buying?
Item: Abivax - ADR
Rating: 0.70558325
Author: Trendlyne DVM scores

about

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is eval...

5.67 -0.38 (-6.28%)

61.43% Fall from 52W High

264.2K XNAS Volume

High vol. this week

XNAS 23 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Abivax - ADR is on 02 Jun 2025 for the purpose of Abivax SA First Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

2.8 / 100

Technically Bearish

25.4 / 100

1Yr Price target upside is 555%

7 analysts

Abivax - ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Abivax - ADR Live Share Price Today, Share Analysis and Chart

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is eval...

61.43% Fall from 52W High

High vol. this week

Abivax - ADR Live Price Chart

Abivax - ADR FAQ

How is Abivax - ADR today?

Abivax - ADR today is trading in the red, and is down by -6.28% at 5.67.

How has Abivax - ADR performed historically?

Abivax - ADR is currently trading down -6.28% on an intraday basis. In the past week the stock fell -5.66%. stock has been down -29.83% in the past quarter and fell -59.21% in the past year. You can view this in the overview section.